BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Non-alcoholic steatohepatitis
1
Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease
12/19/2025 10:39:41 AM | Browse: 101 | Download: 392
2
Comparative evaluation of three traditional herbal formulas on gastrointestinal motility in a mouse model of cold stress-induced dyspepsia
9/18/2025 9:55:58 AM | Browse: 582 | Download: 642
3
Safety and efficacy of efruxifermin in metabolic dysfunction-associated steatohepatitis: A systematic review
9/4/2025 7:48:05 AM | Browse: 475 | Download: 395
4
Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis
6/20/2025 7:30:13 AM | Browse: 145 | Download: 589
5
Are mesenchymal stem/stromal cells a novel avenue for the treatment of non-alcoholic fatty liver disease?
5/26/2025 9:15:10 AM | Browse: 237 | Download: 644
6
Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities
2/24/2025 5:39:17 AM | Browse: 255 | Download: 712
7
Effect of frailty as measured by functional impairment on long-term outcomes in liver transplantation in the United States
2/21/2025 10:12:51 AM | Browse: 183 | Download: 647
8
Machine learning-based models for advanced fibrosis in non-alcoholic steatohepatitis patients: A cohort study
2/18/2025 9:00:42 AM | Browse: 169 | Download: 876
9
Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease
11/26/2024 7:20:28 AM | Browse: 281 | Download: 741
10
Non-invasively differentiate non-alcoholic steatohepatitis by visualizing hepatic integrin αvβ3 expression with a targeted molecular imaging modality
11/6/2024 9:51:01 AM | Browse: 163 | Download: 904
11
Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential
9/23/2024 10:30:40 AM | Browse: 347 | Download: 895
12
Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need
7/1/2024 7:39:37 AM | Browse: 311 | Download: 703
13
Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease
6/21/2024 3:14:32 AM | Browse: 214 | Download: 766
14
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease
5/27/2024 9:35:51 AM | Browse: 349 | Download: 880
15
Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease
5/22/2024 11:33:24 AM | Browse: 370 | Download: 851
16
Gestational diabetes mellitus may predispose to metabolic dysfunction-associated steatotic liver disease
5/22/2024 11:33:24 AM | Browse: 159 | Download: 617
17
Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study
5/10/2024 11:51:40 AM | Browse: 261 | Download: 1212
18
Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we?
4/12/2024 4:45:44 PM | Browse: 187 | Download: 780
19
Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
1/26/2024 7:56:29 AM | Browse: 566 | Download: 1600
20
Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis
12/19/2023 2:09:20 AM | Browse: 672 | Download: 1287
21
Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography
12/6/2023 8:08:49 AM | Browse: 496 | Download: 1593
22
Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review
8/22/2023 7:39:26 AM | Browse: 449 | Download: 1399
23
Antagonizing adipose tissue-derived exosome miR-103-hepatocyte phosphatase and tensin homolog pathway alleviates autophagy in non-alcoholic steatohepatitis: A trans-cellular crosstalk
8/2/2023 9:29:03 AM | Browse: 476 | Download: 1552
24
Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review
7/21/2023 9:10:50 AM | Browse: 506 | Download: 1853
25
Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted
6/25/2023 2:17:08 PM | Browse: 460 | Download: 1194
26
Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index
6/16/2023 9:52:18 AM | Browse: 566 | Download: 1703
27
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease
1/12/2023 10:19:09 AM | Browse: 449 | Download: 1213
28
Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?
1/6/2023 2:52:58 AM | Browse: 470 | Download: 928
29
Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver
9/23/2022 10:13:16 AM | Browse: 740 | Download: 1769
30
Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?
9/23/2022 12:48:56 AM | Browse: 717 | Download: 1534
31
Therapies for non-alcoholic fatty liver disease: A 2022 update
9/23/2022 12:48:56 AM | Browse: 753 | Download: 1714
32
Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis
9/15/2022 1:37:25 PM | Browse: 712 | Download: 1486
33
Transcriptome changes in stages of non-alcoholic fatty liver disease
7/27/2022 1:17:37 PM | Browse: 699 | Download: 1512
34
Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
7/27/2022 1:17:37 PM | Browse: 734 | Download: 1425
35
Minireview: Mechanisms of ductular reaction in non-alcoholic steatohepatitis
5/17/2022 12:57:55 PM | Browse: 748 | Download: 1379
36
Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis
4/29/2022 11:12:04 AM | Browse: 781 | Download: 1540
37
Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations
4/22/2022 10:52:23 AM | Browse: 788 | Download: 1771
38
Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis
4/22/2022 10:52:23 AM | Browse: 880 | Download: 2595
39
Is there a role of lipid-lowering therapies in the management of fatty liver disease?
1/21/2022 8:16:14 AM | Browse: 657 | Download: 1408
40
Abnormal liver enzymes: A review for clinicians
11/24/2021 9:54:22 AM | Browse: 722 | Download: 1386
41
Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study
11/19/2021 11:15:33 AM | Browse: 919 | Download: 2011
42
Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?
10/20/2021 7:18:39 AM | Browse: 774 | Download: 1365
43
Hepatocellular carcinoma in non-alcoholic fatty liver disease: A growing challenge
9/22/2021 8:09:41 AM | Browse: 923 | Download: 1742
44
Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
9/7/2021 8:15:21 AM | Browse: 994 | Download: 1711
45
Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease
5/20/2021 3:14:20 PM | Browse: 832 | Download: 2267
46
Non-alcoholic fatty liver disease and cardiovascular concerns: The time for hepatologist and cardiologist close collaboration
4/28/2021 12:31:49 PM | Browse: 1090 | Download: 1728
47
Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population
3/12/2021 9:59:35 AM | Browse: 1079 | Download: 2220
48
Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?
2/25/2021 3:45:30 PM | Browse: 979 | Download: 2437
49
Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort
2/20/2021 2:51:13 AM | Browse: 899 | Download: 2328
50
Experimental models of metabolic and alcoholic fatty liver disease
12/30/2020 1:59:10 PM | Browse: 1143 | Download: 1982
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.